[Closed for Investment] OsNovum, with a pre-money valuation of $14.4 million, is raising funds on Wefunder. The company has developed a patented-technology to regenerate bones affected by osteoporosis. The technology aims to improve skeletal health and improve the lifespan and quality of life. Gregory Steiner and Roslynn Steiner founded OsNovum in June 2020. The current round of crowdfunding has a minimum goal of $60,750 and a maximum goal of $1,070,000, and the proceeds will be used for FDA tests, ISO certification, regulatory submission, production equipment, product delivery systems, capital improvements, and salaries. OsNovum’s technology is already cleared by the FDA for maxillofacial use and waiting for clearance for skeletal use. The company plans to launch specialty clinics based on its technology.
Investment Overview
Raised: $204,350
Deal Terms
Total Commitments ($USD)
- Platform
- Wefunder
- Start Date
- 12/02/2020
- Close Date
- 03/31/2021
$60,750
$1,070,000
$100
Equity - Preferred
Seed
RegCF
$25.00
$11,999,520
$14,400,000
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- High
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.